Non-Small Cell Lung Cancer
Conditions
Interventions
Case series:No intervention
Sponsors
Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years; 2. Pathologically confirmed patients with resectable stage I-IIIA non-small cell lung cancer; 3. Patient follow-up information is complete, and plasma and peripheral blood samples, as well as paraffin and/or fresh tissue samples of surgical tissue can be obtained; 4. Patients with multiple primary or metastatic lesions (lymph nodes or solitary metastases, etc.) were preferentially enrolled in the group; 5. Subjects read and fully understand the patient's instructions and sign informed consent.
Exclusion criteria
Exclusion criteria: 1.For patients who are unable to obtain tissue and blood samples, blood samples should include at least two time points: pre-operative (d0) and post-operative (d7); 2.Current alcoholics or drug abusers; 3.pregnant women, women planning to become pregnant, or women who are breast feeding should not participate in the study; 4.Active infections of clinical significance or any form of acute disease; 5.The patient had a history of other tumors or had received antineoplastic treatment before admission. 6.It is estimated that patients' compliance to participate in this clinical study is insufficient. 7.Received other drug clinical trials in the past 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| next generation sequencing; | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival;overall survival; | — |
Countries
China
Contacts
Public ContactLin Xu
Outcome results
None listed